‘Digiceuticals,’ new CGM devices, HbA1c alternatives transform diabetes management

CHICAGO — The growing abundance of technology options for better diabetes management and the trend away from HbA1c as the only evaluation metric for the condition are important parallel phenomena, according to a speaker at the Cardiometabolic Health Congress. Anne Peters, MD, director of USC clinical diabetes programs and professor of clinical medicine at the Keck School of Medicine

Healio: ‘Digiceuticals,’ new CGM devices, HbA1c alternatives transform diabetes management

About the Author

Your Name and Title Here!

Use your biography to describe your talent and link to your NutriScape Nutrition Profile. From there, you can provide your contact information and link to website and your Social Media Accounts.

Tags:

Related Posts

Write for NutriScape!